Today: 17 March 2026
Browse Category

NASDAQ:LIMN 3 February 2026

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma (LIMN) jumps in premarket after late-session spike as Nasdaq $1 rule hangs over shares

Liminatus Pharma shares jumped 29.4% to $0.74 in premarket trading Tuesday after surging 64.6% to $0.94 in Monday’s after-hours session. The stock remains below the $1 minimum required for Nasdaq listing, with the company facing a July 14, 2026 deadline to regain compliance. Liminatus disclosed it received a Nasdaq deficiency notice in January. Market cap stood near $15.5 million.
3 February 2026

Stock Market Today

  • Sociedad Quimica y Minera de Chile Shares Surpass Analyst Target Price
    March 17, 2026, 7:38 AM EDT. Shares of Sociedad Quimica y Minera de Chile (SQM) recently rose above the average analyst 12-month target price of $75.92, trading at $76.35. This milestone prompts analysts either to downgrade valuations or adjust their target prices upward, depending on the company's prospects. The average target incorporates input from 13 analysts, ranging from $49.00 to $100.00, with a standard deviation of $19.023. Investor reaction may hinge on whether SQM's valuation is stretched or if stronger fundamentals justify higher prices. Current analyst ratings show 6 strong buys, 6 holds, and 1 sell, maintaining an average rating of 2.15 (1=Strong Buy, 5=Strong Sell). The crossing of the target price encourages market participants to reassess SQM's outlook and potential price trajectory.
Go toTop